anmelden
SPI
20.088,42
PKT
-22,78
PKT
-0,11
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.09.12 | StarragTornos hold | Vontobel Research | |
| 06.09.12 | Holcim neutral | J.P. Morgan Cazenove | |
| 06.09.12 | Richemont neutral | J.P. Morgan Cazenove | |
| 06.09.12 | Swiss Re sell | Goldman Sachs Group Inc. | |
| 06.09.12 | Roche overweight | J.P. Morgan Cazenove | |
| 06.09.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 06.09.12 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 06.09.12 | UBS underperform | Cheuvreux SA | |
| 06.09.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 06.09.12 | Holcim outperform | Cheuvreux SA | |
| 06.09.12 | Holcim hold | ING | |
| 06.09.12 | Roche buy | Sarasin Research | |
| 06.09.12 | Emmi buy | Sarasin Research | |
| 05.09.12 | Swatch (I) outperform | Credit Suisse Group | |
| 05.09.12 | UBS overweight | J.P. Morgan Cazenove | |
| 05.09.12 | UBS overweight | J.P. Morgan Cazenove | |
| 05.09.12 | Partners Group hold | Vontobel Research | |
| 05.09.12 | Kardex hold | Vontobel Research | |
| 05.09.12 | DKSH hold | Vontobel Research | |
| 05.09.12 | Holcim hold | Vontobel Research | |
| 05.09.12 | Novartis reduce | Vontobel Research | |
| 05.09.12 | Swiss Re buy | Vontobel Research | |
| 05.09.12 | Richemont neutral | Sarasin Research | |
| 05.09.12 | Richemont buy | Vontobel Research | |
| 04.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 04.09.12 | Zurich Insurance hold | Deutsche Bank AG | |
| 04.09.12 | Swiss Life buy | Deutsche Bank AG | |
| 04.09.12 | Swiss Life buy | Nomura | |
| 04.09.12 | Helvetia Baloise reduce | Nomura | |
| 04.09.12 | Richemont hold | Deutsche Bank AG | |
| 04.09.12 | Holcim hold | Vontobel Research | |
| 04.09.12 | Sika hold | Vontobel Research | |
| 04.09.12 | Partners Group hold | Vontobel Research | |
| 04.09.12 | Sika neutral | Sarasin Research | |
| 04.09.12 | Partners Group neutral | Sarasin Research | |
| 04.09.12 | UBS hold | ING | |
| 04.09.12 | UBS hold | ING | |
| 03.09.12 | Roche outperform | Credit Suisse Group | |
| 03.09.12 | Swatch (I) overweight | HSBC | |
| 04.09.12 | Richemont neutral | J.P. Morgan Cazenove |
